M-20

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameM-20
Drug Alias NameM-20
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMyeloid differentiation primary response protein MyD88 inhibitors
TargetsMyeloid differentiation primary response protein MyD88
Therapy Area/IndicationsAcute Lung Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWenzhou Medical University
China Registration ClassN/A

Develop Information

Active CompaniesWenzhou Medical University
Inactive CompaniesN/A
Active IndicationsAcute Lung Injury
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A